Markets › United States › NAS › ADXN

Addex Therapeutics Ltd

NAS:ADXNHealthcarenasdaq_composite

$2.89+4.71%At closeAt close · Mon 19 Oct · ≈ AED 10.61 · Market cap — · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	—	—
Operating margin	−338.9%	−531.7%	−741.0%	−139.1%	−681.8%	−9,390.8%	−9,390.8%	+0.0 pts
Net margin	−355.9%	−526.4%	−1,462.6%	−654.5%	1,746.0%	−22,448.4%	−21,803.6%	+644.9 pts
EBITDA margin	−343.5%	−512.3%	−734.9%	−135.8%	−1,149.6%	−22,793.6%	—	—
Return on equity	−88.0%	−90.7%	−423.5%	−921.6%	72.9%	−141.1%	−137.1%	+4.1 pts
Return on assets	−63.7%	−68.1%	−251.2%	−227.4%	66.1%	−105.7%	−102.6%	+3.0 pts
Return on capital employed	−73.9%	−84.2%	−210.8%	−128.3%	−27.9%	−54.5%	—	—
Debt / equity	0.0×	0.0×	0.1×	0.3×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	2.8%	2.1%	4.5%	7.4%	0.4%	0.5%	—	—
Interest coverage	−176.2×	−246.1×	−215.6×	−103.8×	−776.8×	−1,162.6×	—	—
Current ratio	5.4×	5.3×	2.4×	1.5×	4.4×	1.4×	1.4×	+0.0%
Quick ratio	5.3×	5.3×	2.4×	1.5×	4.4×	1.4×	—	—
Cash ratio	5.2×	5.0×	2.1×	1.3×	4.2×	1.4×	1.4×	+0.0%
Asset turnover	0.2×	0.1×	0.2×	0.3×	0.0×	0.0×	—	—
Inventory turnover	0.0×	—	—	—	—	—	—	—
Receivables turnover	52.8×	9.0×	2.4×	10.7×	26.0×	1.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—